Pharm-Rx Bacitracin
- CAS Number
- 1405-87-4
- Chemical Name
- Bacitracin
Pharm-Rx Bacitracin falls under the category hierarchy of the healthcare and pharmaceutical markets. More precisely, it falls under the category of other drug and care solutions, highlighting its role as a component in pharmaceutical applications designed for various healthcare needs.
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Markets
- Healthcare & Pharma
- Definition
Bacitracin is a mixture of polypeptides produced by the growth of an organism of the licheniformis group of Bacillus subtilis (Fam. Bacillacaea), the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin units/mg, calculated on the dried basis.Bacitracin is a mixture of polypeptides produced by the growth of an organism of the licheniformis group of Bacillus subtilis (Fam. Bacillacaea), the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin units/mg, calculated on the dried basis.
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Labelling Information
Where it is packaged for prescription compounding, label it to indicate that it is not sterile and that the potency cannot be assured for longer than 60 days after opening, and to state the number of Bacitracin Units/ mg. Where Bacitracin must be subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. 2S (USP41) Change to read
- USP Reference Standards
- USP Bacitracin Zinc RS (CN 1-May-2018)
